Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 9c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Revenue Growth %: +6.2%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Revenue Growth %: +6.2%
Financial Fact:
Net loss: -3.95M
Today's EPS Names:
ORPB, ONEG, NDLS, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.41, $0.09 better than the analyst estimate of $0.32. Revenue for the quarter came in at $85.4 million versus the consensus estimate of $81.62 million.
GUIDANCE:
Catalyst Pharmaceuticals sees FY2023 revenue of $195-205 million, versus the consensus of $165.8 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gentex Corporation (GNTX) Tops Q2 EPS by 8c ; Offers Guidance
- Lamb Weston (LW) Tops Q4 EPS by 25c; offers guidance
- Oregon Pacific Bancorp (ORPB) Tops Q2 EPS by 38c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
